Free Trial

Tidal Investments LLC Sells 6,632 Shares of Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Tidal Investments LLC decreased its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 32.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,042 shares of the health services provider's stock after selling 6,632 shares during the period. Tidal Investments LLC's holdings in Maximus were worth $1,048,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MMS. Captrust Financial Advisors bought a new stake in shares of Maximus in the 4th quarter worth $276,000. IFP Advisors Inc raised its position in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after acquiring an additional 302 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in Maximus in the fourth quarter worth about $1,113,000. Legato Capital Management LLC lifted its holdings in Maximus by 33.9% in the 4th quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock valued at $2,399,000 after acquiring an additional 8,138 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its position in shares of Maximus by 2.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock valued at $54,748,000 after purchasing an additional 16,772 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Maximus

In related news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.60% of the company's stock.

Maximus Trading Up 0.2%

MMS stock traded up $0.16 during mid-day trading on Friday, reaching $72.26. 47,935 shares of the stock traded hands, compared to its average volume of 560,960. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The stock's fifty day moving average is $69.81 and its 200-day moving average is $71.80. The company has a market cap of $4.07 billion, a P/E ratio of 15.54 and a beta of 0.61. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. The firm had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The company's revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the business posted $1.57 EPS. As a group, sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.66%. Maximus's payout ratio is 23.86%.

Analyst Ratings Changes

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Read Our Latest Stock Analysis on Maximus

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines